Hypertension

This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diuretics and renal denervation therapy. 

renal denervation clinical trial study hypertension vessix boston scientific
News | October 31, 2013
October 31, 2013 — Patients treated with the Boston Scientific Vessix...
News | October 28, 2013
October 28, 2013 — CBSET, a not-for-profit preclinical research institute dedicated to biomedical research, education...
renal denervation therapy hypertension kona medical morningside
News | October 25, 2013
October 25, 2013 — Kona Medical Inc. announced it has closed a Series D equity financing of $10 million. Morningside...
renal denervation, Symplicity

An illustration of how renal denervation therapy is delivered, in this case using a Medtronic Symplicity device.

Feature | October 14, 2013

October 14, 2013 — Since its debut in 2010, the...

News | September 27, 2013

September 27, 2013 — Rox Medical has crossed the halfway point in the CONTROL-HTN international, multi-center,...

News | September 09, 2013

September 9, 2013 -- Among patients with prehypertension and coronary artery disease, use of the renin (an enzyme...

Feature | September 03, 2013

September 3, 2013 — St. Jude Medical Inc. announced the CE mark approval of its next-generation EnligHTN ...

News | August 22, 2013

August 22, 2013 — Qinghui Chen, assistant professor in Michigan Tech’s kinesiology and integrative physiology...

News | August 02, 2013

August 2, 2013 — Mercator MedSystems has been issued U.S. Patent 8,465,752, which protects the company’s sole U.S....

MEDTRONIC, symplicity renal denervation catheter

The Medtronic Symplicity catheter was the first renal denervation system to prove in clinical trials the therapy can lower drug-resistant hypertension.

Feature | July 30, 2013 | Dave Fornell

One of the exciting new frontiers for interventional cardiology is the use of renal denervation therapy to treat...

FDA US device innovation

The delay in being able to bring new medical device advances to market in the United States, such as transcatheter aortic valves and left atrial appendage occluders, has raised the question of the U.S. leadership role in technology innovation.

Feature | July 03, 2013 | Anita Asgar, M.D., FSCAI

The field of interventional cardiology is one of constant change and innovation. The past 10 years have...

News | June 13, 2013

June 13, 2013 — St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval to begin the...

Boston Scientific Vessix Renal Denervation System Hypertension Therapies
News | June 06, 2013

June 6, 2013 — Boston Scientific Corporation reported interim data from the REDUCE-HTN...

News | June 03, 2013

June 3, 2013 — St. Jude Medical Inc. announced that the company’s EnligHTN multi-electrode renal denervation system ...

News | May 30, 2013

May 30, 2013 — Kona Medical announced three and six month results from the WAVE I study, a first-in-man study...

Overlay Init